Search research articles
Contact Us
Filters
Showing results (31-40 of 44) with videos related to
Page
of 5
Sort By:
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer
|
August 25, 2010
[A phase II clinical trial of celecoxib combined with platinum-based chemotherapy in the treatment of patients with advanced NSCLC as first-line treatment.]
Zhijie Wang, Jianchun Duan, Qingzhi Guo, et al.
Plant Physiology and Biochemistry : PPB
|
March 4, 2026
Integrated transcriptomic and metabolomic profiling reveals genotypic differences in UV-B radiation tolerance mechanisms in Elymus sibiricus L
Fei Zhang, Meixiu Chen, Xuyi Liu, et al.
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer
|
March 24, 2011
[Analysis of prognostic factors in 541 female patients with advanced non-small cell lung cancer]
Meina Wu, Yuyan Wang, Tongtong An, et al.
Asia-Pacific Journal of Clinical Oncology
|
August 18, 2012
Phase III, randomized, open-label, first-line study in Asia of gefitinib versus carboplatin/paclitaxel in clinically selected patients with advanced non-small-cell lung cancer: evaluation of patients recruited from mainland China
Yi-Long Wu, Da-Tong Chu, Baohui Han, et al.
Journal of Medicinal Chemistry
|
June 28, 2021
Identification of Novel Fused Heteroaromatics-Based MALT1 Inhibitors by High-Throughput Screening to Treat B Cell Lymphoma
Xuewu Liang, Chenxia Sun, Chunpu Li, et al.
International Journal of Nanomedicine
|
November 18, 2024
A Multifunctional Low-Temperature Photothermal Nanomedicine for Melanoma Treatment via the Oxidative Stress Pathway Therapy
Dou Zhang, Xuyi Liu, Xiong Li, et al.
Frontiers in Microbiology
|
July 14, 2022
Microbial Community Analysis in Sichuan South-road Dark Tea Piled Center at Pile-Fermentation Metaphase and Insight Into Organoleptic Quality Development Mediated by <i>Aspergillus niger</i> M10
Yao Zou, Ying Zhang, Yun Tian, et al.
International Journal of Nanomedicine
|
September 3, 2025
A Hybrid Protein-Oxygen Nanomedicine Overcomes Osimertinib Resistance in NSCLC via HIF-1α/VEGF/EGFR Inhibition
Guanming Jiang, Xuyi Liu, Dou Zhang, et al.
Thoracic Cancer
|
January 15, 2016
Patients harboring epidermal growth factor receptor (EGFR) double mutations had a lower objective response rate than those with a single mutation in non-small cell lung cancer when treated with EGFR-tyrosine kinase inhibitors
Zhigang Wei, Tongtong An, Zhijie Wang, et al.
Journal of Medicinal Chemistry
|
February 15, 2021
Discovery of Novel Pyrrolo[2,3-<i>d</i>]pyrimidine-based Derivatives as Potent JAK/HDAC Dual Inhibitors for the Treatment of Refractory Solid Tumors
Xuewu Liang, Shuai Tang, Xuyi Liu, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 44) with videos related to
Sort By:
Page
of 5
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer
|
August 25, 2010
[A phase II clinical trial of celecoxib combined with platinum-based chemotherapy in the treatment of patients with advanced NSCLC as first-line treatment.]
Zhijie Wang, Jianchun Duan, Qingzhi Guo, et al.
Plant Physiology and Biochemistry : PPB
|
March 4, 2026
Integrated transcriptomic and metabolomic profiling reveals genotypic differences in UV-B radiation tolerance mechanisms in Elymus sibiricus L
Fei Zhang, Meixiu Chen, Xuyi Liu, et al.
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer
|
March 24, 2011
[Analysis of prognostic factors in 541 female patients with advanced non-small cell lung cancer]
Meina Wu, Yuyan Wang, Tongtong An, et al.
Asia-Pacific Journal of Clinical Oncology
|
August 18, 2012
Phase III, randomized, open-label, first-line study in Asia of gefitinib versus carboplatin/paclitaxel in clinically selected patients with advanced non-small-cell lung cancer: evaluation of patients recruited from mainland China
Yi-Long Wu, Da-Tong Chu, Baohui Han, et al.
Journal of Medicinal Chemistry
|
June 28, 2021
Identification of Novel Fused Heteroaromatics-Based MALT1 Inhibitors by High-Throughput Screening to Treat B Cell Lymphoma
Xuewu Liang, Chenxia Sun, Chunpu Li, et al.
International Journal of Nanomedicine
|
November 18, 2024
A Multifunctional Low-Temperature Photothermal Nanomedicine for Melanoma Treatment via the Oxidative Stress Pathway Therapy
Dou Zhang, Xuyi Liu, Xiong Li, et al.
Frontiers in Microbiology
|
July 14, 2022
Microbial Community Analysis in Sichuan South-road Dark Tea Piled Center at Pile-Fermentation Metaphase and Insight Into Organoleptic Quality Development Mediated by <i>Aspergillus niger</i> M10
Yao Zou, Ying Zhang, Yun Tian, et al.
International Journal of Nanomedicine
|
September 3, 2025
A Hybrid Protein-Oxygen Nanomedicine Overcomes Osimertinib Resistance in NSCLC via HIF-1α/VEGF/EGFR Inhibition
Guanming Jiang, Xuyi Liu, Dou Zhang, et al.
Thoracic Cancer
|
January 15, 2016
Patients harboring epidermal growth factor receptor (EGFR) double mutations had a lower objective response rate than those with a single mutation in non-small cell lung cancer when treated with EGFR-tyrosine kinase inhibitors
Zhigang Wei, Tongtong An, Zhijie Wang, et al.
Journal of Medicinal Chemistry
|
February 15, 2021
Discovery of Novel Pyrrolo[2,3-<i>d</i>]pyrimidine-based Derivatives as Potent JAK/HDAC Dual Inhibitors for the Treatment of Refractory Solid Tumors
Xuewu Liang, Shuai Tang, Xuyi Liu, et al.
Page
of 5